FDA NDC Directory · JSON-LD · Markdown

Sylvant

NDC 73090-421 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, FOR SOLUTION

Generic nameSiltuximab
Labeler / ManufacturerRecordati Rare Diseases, Inc.
Marketing categoryBiologic License Application · App BLA125496
Dosage form / routeINJECTION, POWDER, FOR SOLUTION · INTRAVENOUS
Active ingredientsSILTUXIMAB (400 mg/1)
Marketing started20140423
Package count1

External sources

Source: openFDA. Public-domain (CC0).